Impact of receiving recorded mental health recovery narratives on quality of life in people experiencing non-psychosis mental health problems (NEON-O Trial): updated randomised controlled trial protocol.

MANSA Mental health Online trial Open recruitment Pragmatic trial Quality of life Randomised controlled trial Recovery narratives Recovery stories

Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
29 Jan 2022
Historique:
received: 27 11 2020
accepted: 13 01 2022
entrez: 30 1 2022
pubmed: 31 1 2022
medline: 2 2 2022
Statut: epublish

Résumé

Mental health recovery narratives are first-person lived experience accounts of recovery from mental health problems, which refer to events or actions over a period of time, and which include elements of adversity or struggle, and also self-defined or observable strengths, successes, or survival. Recorded recovery narratives are those presented in invariant form, including text, audio, or video. In a previous publication, we presented a protocol for three pragmatic trials of the Narrative Experiences Online (NEON) Intervention, a web application recommending recorded recovery narratives to participants. The aim of the definitive NEON Trial was to understand whether the NEON Intervention benefitted people with experience of psychosis. The aim of the smaller NEON-O and NEON-C trials was to evaluate the feasibility of conducting definitive trials of the NEON Intervention with people (1) experiencing non-psychosis mental health problems and (2) who informally care for others experiencing mental health problems. An open recruitment strategy with a 60-week recruitment period was developed. Recruitment for the NEON Trial and NEON-O Trial targeted mental health service users and people not using mental health services. The NEON Trial recruited to time and target. The NEON-O Trial achieved its target in 10 weeks. Analysis considered by a Programme Steering Committee after the target was achieved demonstrated a definitive result could be obtained if the trial was adapted for recruitment to continue. The UK Health Research Authority approved all needed amendments following ethical review. To describe the decision-making process for amending the NEON-O Trial and to describe amendments made to the NEON-O Trial to enable a definitive result. The article describes amendments to the aims, objectives, design, power calculation, recruitment rate, process evaluation design, and informed consent documents. The extended NEON-O Trial adopts analysis principles previously specified for the NEON Trial. The article provides a model for other studies adapting feasibility trials into definitive trials. All trials prospectively registered. NEON Trial: ISRCTN11152837 . Registered on 13th August 2018. NEON-C Trial: ISRCTN76355273 . Registered on 9th January 2020. NEON-O Trial: ISRCTN63197153 . Registered on 9th January 2020. The NEON-O Trial ISRCTN was updated when amendments were approved. Amendment details: NOSA2, 30th October 2020.

Sections du résumé

BACKGROUND BACKGROUND
Mental health recovery narratives are first-person lived experience accounts of recovery from mental health problems, which refer to events or actions over a period of time, and which include elements of adversity or struggle, and also self-defined or observable strengths, successes, or survival. Recorded recovery narratives are those presented in invariant form, including text, audio, or video. In a previous publication, we presented a protocol for three pragmatic trials of the Narrative Experiences Online (NEON) Intervention, a web application recommending recorded recovery narratives to participants. The aim of the definitive NEON Trial was to understand whether the NEON Intervention benefitted people with experience of psychosis. The aim of the smaller NEON-O and NEON-C trials was to evaluate the feasibility of conducting definitive trials of the NEON Intervention with people (1) experiencing non-psychosis mental health problems and (2) who informally care for others experiencing mental health problems. An open recruitment strategy with a 60-week recruitment period was developed. Recruitment for the NEON Trial and NEON-O Trial targeted mental health service users and people not using mental health services. The NEON Trial recruited to time and target. The NEON-O Trial achieved its target in 10 weeks. Analysis considered by a Programme Steering Committee after the target was achieved demonstrated a definitive result could be obtained if the trial was adapted for recruitment to continue. The UK Health Research Authority approved all needed amendments following ethical review.
PURPOSE OF THIS ARTICLE UNASSIGNED
To describe the decision-making process for amending the NEON-O Trial and to describe amendments made to the NEON-O Trial to enable a definitive result. The article describes amendments to the aims, objectives, design, power calculation, recruitment rate, process evaluation design, and informed consent documents. The extended NEON-O Trial adopts analysis principles previously specified for the NEON Trial. The article provides a model for other studies adapting feasibility trials into definitive trials.
TRIAL REGISTRATION BACKGROUND
All trials prospectively registered. NEON Trial: ISRCTN11152837 . Registered on 13th August 2018. NEON-C Trial: ISRCTN76355273 . Registered on 9th January 2020. NEON-O Trial: ISRCTN63197153 . Registered on 9th January 2020. The NEON-O Trial ISRCTN was updated when amendments were approved. Amendment details: NOSA2, 30th October 2020.

Identifiants

pubmed: 35093141
doi: 10.1186/s13063-022-06027-z
pii: 10.1186/s13063-022-06027-z
pmc: PMC8800358
doi:

Substances chimiques

Neon 4VB4Y46AHD

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

90

Subventions

Organisme : Programme Grants for Applied Research
ID : RP-PG-0615-20016

Informations de copyright

© 2022. The Author(s).

Références

Front Psychiatry. 2020 Oct 30;11:589731
pubmed: 33192738
Int J Soc Psychiatry. 1999 Spring;45(1):7-12
pubmed: 10443245
Can J Psychiatry. 2019 Oct;64(10):669-679
pubmed: 31046432
J Consult Clin Psychol. 2020 Mar;88(3):179-195
pubmed: 32068421
BMC Psychiatry. 2013 Jun 26;13:173
pubmed: 23802602
JMIR Ment Health. 2020 Sep 18;7(9):e16290
pubmed: 32945771
PLoS One. 2019 Mar 28;14(3):e0214678
pubmed: 30921432
Soc Psychiatry Psychiatr Epidemiol. 2020 Mar;55(3):295-308
pubmed: 31654089
BMJ Open. 2019 Jun 28;9(6):e029342
pubmed: 31256037
JMIR Form Res. 2021 May 27;5(5):e24417
pubmed: 34042595
JMIR Ment Health. 2019 Oct 4;6(10):e14233
pubmed: 31588912
Trials. 2021 Jul 9;22(1):441
pubmed: 34243794
J Med Internet Res. 2005 Mar 19;7(1):e6
pubmed: 15829478
Trials. 2020 Jul 20;21(1):661
pubmed: 32690105
PLoS One. 2019 Dec 13;14(12):e0226201
pubmed: 31834902

Auteurs

Stefan Rennick-Egglestone (S)

School of Health Sciences, Institute of Mental Health, University of Nottingham Innovation Park, Triumph Road, Nottingham, NG7 2TU, UK. stefan.egglestone@nottingham.ac.uk.

Rachel Elliott (R)

Division of Population Health, Health Services Research & Primary Care, University of Manchester, Oxford Road, Manchester, M13 9PL, UK.

Chris Newby (C)

School of Medicine, Institute of Mental Health, University of Nottingham Innovation Park, Triumph Road, Nottingham, NG7 2TU, UK.

Clare Robinson (C)

Centre for Primary Care & Public Health, Pragmatic Clinical Trials Unit, Queen Mary University of London, 58 Turner St, London, E1 2AB, UK.

Mike Slade (M)

School of Health Sciences, Institute of Mental Health, University of Nottingham Innovation Park, Triumph Road, Nottingham, NG7 2TU, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH